Alumis Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ALMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
280 East Grand Avenue, South San Francisco, CA

Insiders trading volume in the past year

Alumis Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foresite Capital Management V, LLC 10%+ Owner $67.2M Jul 1, 2024
AyurMaya Capital Management Company, LP Director, Other*, 10%+ Owner $65.6M May 21, 2025
Srinivas Akkaraju Director $20.8M +$1.48M +7.65% Jul 30, 2025
James B. Tananbaum Director, 10%+ Owner $18.4M +$202K +1.11% May 2, 2025
Foresite Labs, LLC 10%+ Owner $18.4M +$202K +1.11% May 2, 2025
Foresite Capital Management VI LLC 10%+ Owner $18.4M +$202K +1.11% May 2, 2025
Roy C. Hardiman Chief Business & Strategy Ofcr $949K Jul 29, 2025
Sara Klein Chief Legal Officer $541K Feb 18, 2025
Martin Babler President, CEO and Chairman, Director $488K +$101K +26% Jul 29, 2025
Mark Christopher Bradley Chief Development Officer $307K Jul 29, 2025
Derrick Richardson SVP, People and Culture $191K Jul 29, 2025
David M. Goldstein Chief Scientific Officer $174K Jul 29, 2025
Alan Colowick Director $138K +$130K +1548% Apr 1, 2025
Jorn Drappa Chief Medical Officer $127K Jul 29, 2025
John R. Schroer Chief Financial Officer $125K Jul 29, 2025
Sanam Pangali Chief Legal Officer $49.6K Jul 29, 2025
Patrick Machado Director $30.6K Jul 30, 2025
Lynn A. Tetrault Director Jul 30, 2025
Zhengbin Yao Director Jul 30, 2025
Sapna Srivastava Director Jul 30, 2025

Recent Insider Transactions by Companies or Individuals for Alumis Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.